Ticker Details
ICU Medical, Inc. ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$4.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.46 | 1.38%
Avg Daily Range (30 D):	$2.69 | 1.62%
Avg Daily Range (90 D):	$2.32 | 1.60%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	32
Avg Trade Size (Sh.) (90 D):	33

Institutional Trades
Total Institutional Trades:	3,725
Avg Institutional Trade:	$3.88M
Avg Institutional Trade (30 D):	$6.14M
Avg Institutional Trade (90 D):	$6.04M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.91M
Avg Closing Trade (30 D):	$7.6M
Avg Closing Trade (90 D):	$7.62M
Avg Closing Volume:	31.58K

News

Jun 10, 2026 @ 11:36 PM ICU Medical's General Counsel Sells — The S... Source: Seena Hassouna

Mar 25, 2026 @ 12:01 PM EXCLUSIVE: Petrochemical Crunch From Iran War Isn'... Source: Eva Mathew

Mar 13, 2026 @ 8:30 AM Intravenous (IV) Solutions Market Size to Reach US... Source: Sns Insider

Mar 9, 2026 @ 10:30 PM [Latest] Global Intravenous Infusion Pump Market S... Source: Custom Market Insights

Aug 8, 2025 @ 1:15 AM ICU Medical (ICUI) Q2 EPS Jumps 40% Source: Jesterai

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.2	$.76	$1.22
Diluted EPS	$1.19	$.76	$1.2
Revenue	$2.16B	$551.68M	$530.23M
Gross Profit	$845.15M	$235.05M	$206.23M
Net Income / Loss	$30.09M	$19.09M	$30.13M
Operating Income / Loss	$72.06M	$39.13M	$13.58M
Cost of Revenue	$1.31B	$316.63M	$324M
Net Cash Flow	$-1.73M	$9.97M	$-19.63M
PE Ratio

Splits
Mar 18, 2002	3:2